Reports related to this article:
In what is described as the largest foreign takeover by a Japanese company, drug maker Takeda's $62 billion purchase of Shire Plc is now complete. The two companies generate a combined $30 billion annual revenue. Under the deal, Takeda acquired Shire's recently-opened $1 billion immunoglobulin plasma fractionation plant in Covington, Georgia. The company is the site's fourth owner, having changed hands three other times since construction began in 2013.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Explore Our ToolsRelated Articles
-
Life-Science New Build Report: 200 North American Sites in P...November 04, 2014
-
Pharma-Biotech Industry Capital Investment Tops $12 Billion ...January 14, 2014
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
View ReportsIndustry Intel
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1, CDMO and ReshoringPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026